ArticleCardiology and therapy2020

Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study.

Masahiro Yasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.